Diagnostic Cytopathology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 0.9 | Q4 | 18.2% | 0.327 | Q3 | 46.4% |
| 2024 | 1.0 | Q4 | 27.3% | 0.377 | Q3 | 53.1% |
| 2023 | 1.0 | Q4 | 17.9% | 0.411 | Q3 | 58.5% |
| 2022 | 1.3 | Q4 | 24.7% | 0.433 | Q2 | 61.7% |
| 2021 | 1.4 | Q4 | 27.6% | 0.415 | Q3 | 61.4% |
| 2020 | — | — | 0.417 | Q3 | 60.7% | |
| 2019 | — | — | 0.441 | Q3 | 63.7% | |
| 2018 | — | — | 0.562 | Q2 | 68.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
8755-1039
ISSN
1097-0339
country
UScoverage
1985-2026